Text with patent numbers: |
|
||||||||||||||||||||||||
Title: | |||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||
Specification: | |||||||||||||||||||||||||
Claims: | |||||||||||||||||||||||||
Inventor: | |||||||||||||||||||||||||
Assg. orig: | |||||||||||||||||||||||||
Assg. curr: | |||||||||||||||||||||||||
Expiry from: | to: | ||||||||||||||||||||||||
Priority from:sa | to: | ||||||||||||||||||||||||
Ref. by: | and more | Ind.cl: | and shorter | ||||||||||||||||||||||
Entity: | Type: | Expired: | Maint.status: | ||||||||||||||||||||||
Score from: | % to: % | Current assig. owns from to patents |
patent | score | priority | expiry | expired | references | current assignee | title |
---|---|---|---|---|---|---|---|
RE45183 | 13 | 2004-01-06 | 2025-01-06 | 1 | 5 | Novo Nordisk A/S; | Heteroaryl-ureas and their use as glucokinase activators |
8431575 | 14 | 2010-02-18 | 2031-03-09 | 0 | 5 | VTVX HOLDINGS I LLC; VTV THERAPEUTICS LLC; | Phenyl-heteroaryl derivatives and methods of use thereof |
7851636 | 15 | 2004-01-06 | 2025-01-06 | 1 | 5 | VTV THERAPEUTICS LLC; | Heteroaryl-ureas and their use as glucokinase activators |
8263634 | 29 | 2004-01-06 | 2025-01-06 | 1 | 5 | VTV THERAPEUTICS LLC; | Heteroaryl-ureas and their use as glucokinase activators |
8741900 | 80 | 2010-02-18 | 2031-02-15 | 0 | 3 | VTVX HOLDINGS I LLC; VTV THERAPEUTICS LLC; | Phenyl-heteroaryl derivatives and methods of use thereof |
9045461 | 80 | 2010-02-18 | 2031-02-15 | 0 | 3 | VTVX HOLDINGS I LLC; VTV THERAPEUTICS LLC; | Phenyl-heteroaryl derivatives and methods of use thereof |
7598391 | 87 | 2004-01-06 | 2025-01-06 | 1 | 11 | VTV THERAPEUTICS LLC; | Heteroaryl-ureas and their use as glucokinase activators |
11150460 | 87 | 2014-05-29 | 2035-07-05 | 0 | 0 | Leica Microsystems CMS GmbH; | Cell culture microscopy slides |
11897586 | 93 | 2021-07-30 | 2042-10-15 | 0 | 0 | L3HARRIS TECHNOLOGIES, INC.; | Surface vessel fueling systems and methods |
8211925 | 94 | 2006-04-28 | 2027-10-21 | 1 | 0 | VTVX HOLDINGS I LLC; VTV THERAPEUTICS LLC; | Benzamide glucokinase activators |
7872139 | 96 | 2004-01-06 | 2025-01-06 | 1 | 5 | Novo Nordisk A/S; | Heteroaryl-ureas and their use as glucokinase activators |